{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:02:05Z","timestamp":1774576925269,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2021YFF0901404"],"award-info":[{"award-number":["2021YFF0901404"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary brainstem lymphoma (PBSL) is rare and generally has a poor prognosis. This study aimed to analyze the clinical, therapeutic, and prognostic factors in a single-center retrospective cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty-six patients diagnosed with PBSL from January 2018 to December 2022 were retrospectively enrolled. Data on the clinical course of disease, pathological parameters, neuroradiological imaging, laboratory results, and survival data were collected and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age at diagnosis was 56 years (range: 10-77), and 23 (41.1%) patients had a Karnofsky Performance Score \u226460. The mid-brain was the most commonly involved brainstem region (35.7%). The histological type of all patients was diffuse large B-cell lymphoma. The first-line treatment was high-dose methotrexate (HD-MTX)-based chemotherapy, with an overall response rate (ORR) of 70.5%, of which 62.1% achieved complete response. For relapsed or refractory disease, radiotherapy was the most common salvage therapy and significantly improved overall survival (OS). With a median follow-up of 56 months, the median OS for the entire cohort was 30 months (95% CI 18-42 months). In both univariate and multivariate analysis, an age of \u226560 years at diagnosis was a significant prognostic factor for poor OS (hazard ratio [HR] 3.086, P = .003, 95% CI 1.467-6.492) and progression-free survival (HR 2.309, P = .030, 95% CI 1.087-4.905).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PBSL has worse survival outcomes compared to tumors in other sites. HD-MTX chemotherapy remains effective, achieving a high ORR. Radiotherapy is an important salvage alternative for rapidly reducing brainstem lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyaf105","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T07:38:35Z","timestamp":1745221115000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary brainstem lymphoma: clinical characteristics, treatment methods, and prognostic factors of 56 patients"],"prefix":"10.1093","volume":"31","author":[{"given":"Wenhui","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiefei","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoubo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gehong","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Tiantan Hospital, Capital Medical University , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neuro-oncology, Cancer Center , Beijing Tiantan Hospital, Capital Medical University, Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"2026032621423710600_oyaf105-B1","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Primary CNS lymphoma","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026032621423710600_oyaf105-B2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/WCO.0000000000001115","article-title":"Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies","volume":"35","author":"Hern\u00e1ndez-Verdin","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"2026032621423710600_oyaf105-B3","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/1097-0142(19831201)52:11<1993::AID-CNCR2820521104>3.0.CO;2-C","article-title":"Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases","volume":"52","author":"Mendenhall","year":"1983","journal-title":"Cancer"},{"key":"2026032621423710600_oyaf105-B4","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1002\/cam4.4272","article-title":"Stereotactic biopsy for adult brainstem lesions: a surgical approach and its diagnostic value according to the 2016 World Health Organization Classification","volume":"10","author":"Chang","year":"2021","journal-title":"Cancer Med"},{"key":"2026032621423710600_oyaf105-B5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ferreri","year":"2003","journal-title":"J Clin Oncol"},{"key":"2026032621423710600_oyaf105-B6","first-page":"422","article-title":"Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial","volume":"19","author":"Tabouret","year":"2017","journal-title":"Neuro Oncol"},{"key":"2026032621423710600_oyaf105-B7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2020008377","article-title":"Primary central nervous system lymphoma","volume":"140","author":"Schaff","year":"2022","journal-title":"Blood"},{"key":"2026032621423710600_oyaf105-B8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14791\/btrt.2016.4.2.155","article-title":"A case of primary central nervous system lymphoma located at brain stem in a child","volume":"4","author":"Kim","year":"2016","journal-title":"Brain Tumor Res Treat"},{"key":"2026032621423710600_oyaf105-B9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2169\/internalmedicine.52.8786","article-title":"Rapid eye movement sleep behavior disorder in a patient with brainstem lymphoma","volume":"52","author":"Jianhua","year":"2013","journal-title":"Intern Med"},{"key":"2026032621423710600_oyaf105-B10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0035-3787(05)85157-4","article-title":"[Primary central nervous system lymphoma presenting with central neurogenic hyperventilation. A case report and review of the literature","volume":"161","author":"Laigle-Donadey","year":"2005","journal-title":"Rev Neurol (Paris)"},{"key":"2026032621423710600_oyaf105-B11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.surneu.2004.12.028","article-title":"Primary central nervous system lymphoma of the brain stem responding favorably to radiosurgery: a case report and literature review","volume":"64","author":"Campbell","year":"2005","journal-title":"Surg Neurol"},{"key":"2026032621423710600_oyaf105-B12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamaneurol.2013.1578","article-title":"Diffusely infiltrating central nervous system lymphoma involving the brainstem in an immune-competent patient","volume":"71","author":"Alsherbini","year":"2014","journal-title":"JAMA Neurol"},{"key":"2026032621423710600_oyaf105-B13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.72.2.271","article-title":"B cell lymphoma of the brain stem masquerading as myasthenia","volume":"72","author":"Shams","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026032621423710600_oyaf105-B14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1468-1331.1999.660721.x","article-title":"Bilateral symmetrical enhancing brainstem lesions: an unusual presentation of primary CNS lymphoma","volume":"6","author":"Larner","year":"1999","journal-title":"Eur J Neurol"},{"key":"2026032621423710600_oyaf105-B15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01059956","article-title":"Primary central nervous system lymphoma presenting as autonomic dysfunction","volume":"23","author":"Ficker","year":"1995","journal-title":"J Neurooncol"},{"key":"2026032621423710600_oyaf105-B16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1212\/WNL.43.2.377","article-title":"Primary T-cell lymphoma of the brainstem","volume":"43","author":"McCue","year":"1993","journal-title":"Neurology"},{"key":"2026032621423710600_oyaf105-B17","doi-asserted-by":"crossref","first-page":"829048","DOI":"10.3389\/fsurg.2022.829048","article-title":"Primary brainstem lymphoma: a population-based study","volume":"9","author":"Chen","year":"2022","journal-title":"Front Surg"},{"key":"2026032621423710600_oyaf105-B18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non- Hodgkin\u2019s lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"2026032621423710600_oyaf105-B19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/jnnp.2009.174250","article-title":"Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only","volume":"80","author":"Rachinger","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026032621423710600_oyaf105-B20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3171\/jns.1986.65.5.0600","article-title":"Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature","volume":"65","author":"Murray","year":"1986","journal-title":"J Neurosurg"},{"key":"2026032621423710600_oyaf105-B21","doi-asserted-by":"crossref","first-page":"769895","DOI":"10.3389\/fonc.2022.769895","article-title":"Clinical impact of the histopatho-logical index and neuroimaging features status in primary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis of 51 cases","volume":"12","author":"Qi","year":"2022","journal-title":"Front Oncol"},{"key":"2026032621423710600_oyaf105-B22","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cam4.2872","article-title":"A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med"},{"key":"2026032621423710600_oyaf105-B23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-019-2718-9","article-title":"Brainstem dysfunction in critically ill patients","volume":"24","author":"Benghanem","year":"2020","journal-title":"Crit Care"},{"key":"2026032621423710600_oyaf105-B24","first-page":"111","article-title":"Magnetic resonance imaging compared with biopsy in the diagnosis of brainstem diseases of childhood: a multicenter review","volume":"106","author":"Schumacher","year":"2007","journal-title":"J Neurosurg"},{"key":"2026032621423710600_oyaf105-B25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1227\/NEU.0b013e31828bf445","article-title":"Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases","volume":"72","author":"Kickingereder","year":"2013","journal-title":"Neurosurgery"},{"key":"2026032621423710600_oyaf105-B26","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1002\/jcp.29790","article-title":"Advances and challenges in the treatment of primary central nervous system lymphoma","volume":"235","author":"Yang","year":"2020","journal-title":"J Cell Physiol"},{"key":"2026032621423710600_oyaf105-B27","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0140-6736(09)61416-1","article-title":"International Extranodal Lymphoma Study Group (IELSG). High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial","volume":"374","author":"Ferreri","year":"2009","journal-title":"Lancet"},{"key":"2026032621423710600_oyaf105-B28","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2352-3026(16)00036-3","article-title":"International Extranodal Lymphoma Study Group (IELSG). Chemoimmuno-therapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial","volume":"3","author":"Ferreri","year":"2016","journal-title":"Lancet Haematol"},{"key":"2026032621423710600_oyaf105-B29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/neuonc\/noy192","article-title":"Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma","volume":"21","author":"Grommes","year":"2019","journal-title":"Neuro Oncol"},{"key":"2026032621423710600_oyaf105-B30","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1212\/WNL.0000000000008900","article-title":"Management and outcome of primary CNS lymphoma in the modern era: an LOC network study","volume":"94","author":"Houillier","year":"2020","journal-title":"Neurology"},{"key":"2026032621423710600_oyaf105-B31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/neuonc\/now033","article-title":"Primary CNS lymphoma at first relapse\/progression: characteristics, management, and outcome of 256 patients from the French LOC network","volume":"18","author":"Langner-Lemercier","year":"2016","journal-title":"Neuro Oncol"},{"key":"2026032621423710600_oyaf105-B32","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2007.13.5533","article-title":"Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle Osseuse-Th\u00e9rapie Cellulaire. Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle Osseuse-Th\u00e9rapie Cellulaire","volume":"26","author":"Soussain","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026032621423710600_oyaf105-B33","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2005.01.161","article-title":"Results of whole-brain radiation as salvage of methotrexate failure for immuno-competent patients with primary CNS lymphoma","volume":"23","author":"Nguyen","year":"2005","journal-title":"J Clin Oncol"},{"key":"2026032621423710600_oyaf105-B34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000276986.19602.c1","article-title":"Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma","volume":"69","author":"Hottinger","year":"2007","journal-title":"Neurology"},{"key":"2026032621423710600_oyaf105-B35","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archneur.62.10.1595","article-title":"Delayed neurotoxicity in primary central nervous system lymphoma","volume":"62","author":"Omuro","year":"2005","journal-title":"Arch Neurol"},{"key":"2026032621423710600_oyaf105-B36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.6004\/jnccn.2020.7667","article-title":"Challenges in the treatment of newly diagnosed and recurrent primary central nervous system lymphoma","volume":"18","author":"Holdhoff","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"2026032621423710600_oyaf105-B37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1200\/JCO.23.01574","article-title":"CD5 gene signature identifies diffuse large B-cell lymphomas sensitive to Bruton\u2019s tyrosine kinase inhibition","volume":"42","author":"Cooper","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026032621423710600_oyaf105-B38","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1200\/JCO.2006.08.2941","article-title":"Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model","volume":"24","author":"Abrey","year":"2006","journal-title":"J Clin Oncol"},{"key":"2026032621423710600_oyaf105-B39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2016.01.016","article-title":"A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma","volume":"57","author":"Jang","year":"2016","journal-title":"Eur J Cancer"},{"key":"2026032621423710600_oyaf105-B40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-024-04665-8","article-title":"Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma","volume":"168","author":"Duan","year":"2024","journal-title":"J Neurooncol"},{"key":"2026032621423710600_oyaf105-B41","doi-asserted-by":"crossref","first-page":"618694","DOI":"10.3389\/fonc.2021.618694","article-title":"Complete blood count score model predicts inferior prognosis in primary central nervous system lymphoma","volume":"11","author":"Feng","year":"2021","journal-title":"Front Oncol"},{"key":"2026032621423710600_oyaf105-B42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.annonc.2022.11.002","article-title":"Molecular and clinical diversity in primary central nervous system lymphoma","volume":"34","author":"Hern\u00e1ndez-Verdin","year":"2023","journal-title":"Ann Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/4\/oyaf105\/67558148\/oyaf105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/4\/oyaf105\/67558148\/oyaf105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T01:42:49Z","timestamp":1774575769000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyaf105\/8542453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyaf105","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,25]]},"article-number":"oyaf105"}}